Annual CFF
$10.99 M
+$12.31 M+938.67%
December 31, 2023
Summary
- As of February 7, 2025, ALLR annual cash flow from financing activities is $10.99 million, with the most recent change of +$12.31 million (+938.67%) on December 31, 2023.
- During the last 3 years, ALLR annual CFF has risen by +$4.96 million (+82.25%).
- ALLR annual CFF is now -67.49% below its all-time high of $33.82 million, reached on December 31, 2021.
Performance
ALLR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.87 M
-$21.44 M-81.50%
September 1, 2024
Summary
- As of February 7, 2025, ALLR quarterly cash flow from financing activities is $4.87 million, with the most recent change of -$21.44 million (-81.50%) on September 1, 2024.
- Over the past year, ALLR quarterly CFF has increased by +$3.49 million (+252.75%).
- ALLR quarterly CFF is now -81.50% below its all-time high of $26.31 million, reached on June 1, 2024.
Performance
ALLR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$33.08 M
-$1.58 M-4.56%
September 1, 2024
Summary
- As of February 7, 2025, ALLR TTM cash flow from financing activities is $33.08 million, with the most recent change of -$1.58 million (-4.56%) on September 1, 2024.
- Over the past year, ALLR TTM CFF has increased by +$21.86 million (+194.90%).
- ALLR TTM CFF is now -4.56% below its all-time high of $34.66 million, reached on June 1, 2024.
Performance
ALLR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ALLR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +938.7% | +252.8% | +194.9% |
| 3 y3 years | +82.3% | +252.8% | +194.9% |
| 5 y5 years | -1.9% | +252.8% | +194.9% |
ALLR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.5% | +938.7% | -81.5% | +310.6% | -4.6% | +2623.2% |
| 5 y | 5-year | -67.5% | +938.7% | -81.5% | +310.6% | -4.6% | +2623.2% |
| alltime | all time | -67.5% | +938.7% | -81.5% | +310.6% | -4.6% | +2623.2% |
Allarity Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.87 M(-81.5%) | $33.08 M(-4.6%) |
| Jun 2024 | - | $26.31 M(+1806.4%) | $34.66 M(+209.0%) |
| Mar 2024 | - | $1.38 M(+164.4%) | $11.22 M(+2.0%) |
| Dec 2023 | $10.99 M(-938.7%) | $522.00 K(-91.9%) | $10.99 M(-4.2%) |
| Sep 2023 | - | $6.45 M(+125.1%) | $11.47 M(+128.4%) |
| Jun 2023 | - | $2.87 M(+147.4%) | $5.02 M(-3383.0%) |
| Mar 2023 | - | $1.16 M(+15.8%) | -$153.00 K(-88.3%) |
| Dec 2022 | -$1.31 M | $1.00 M(>+9900.0%) | -$1.31 M(-108.1%) |
| Sep 2022 | - | $0.00(-100.0%) | $16.13 M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$2.31 M(<-9900.0%) | $18.47 M(-41.3%) |
| Mar 2022 | - | $0.00(-100.0%) | $31.49 M(-6.9%) |
| Dec 2021 | $33.82 M(+460.6%) | $18.44 M(+685.9%) | $33.82 M(+119.9%) |
| Sep 2021 | - | $2.35 M(-78.1%) | $15.38 M(-6.0%) |
| Jun 2021 | - | $10.71 M(+360.6%) | $16.37 M(+189.3%) |
| Mar 2021 | - | $2.33 M(-30.2%) | $5.66 M(+69.8%) |
| Dec 2020 | $6.03 M(-46.1%) | - | - |
| Sep 2020 | - | $3.33 M | $3.33 M |
| Dec 2019 | $11.20 M | - | - |
FAQ
- What is Allarity Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Allarity Therapeutics?
- What is Allarity Therapeutics annual CFF year-on-year change?
- What is Allarity Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Allarity Therapeutics?
- What is Allarity Therapeutics quarterly CFF year-on-year change?
- What is Allarity Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Allarity Therapeutics?
- What is Allarity Therapeutics TTM CFF year-on-year change?
What is Allarity Therapeutics annual cash flow from financing activities?
The current annual CFF of ALLR is $10.99 M
What is the all time high annual CFF for Allarity Therapeutics?
Allarity Therapeutics all-time high annual cash flow from financing activities is $33.82 M
What is Allarity Therapeutics annual CFF year-on-year change?
Over the past year, ALLR annual cash flow from financing activities has changed by +$12.31 M (+938.67%)
What is Allarity Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ALLR is $4.87 M
What is the all time high quarterly CFF for Allarity Therapeutics?
Allarity Therapeutics all-time high quarterly cash flow from financing activities is $26.31 M
What is Allarity Therapeutics quarterly CFF year-on-year change?
Over the past year, ALLR quarterly cash flow from financing activities has changed by +$3.49 M (+252.75%)
What is Allarity Therapeutics TTM cash flow from financing activities?
The current TTM CFF of ALLR is $33.08 M
What is the all time high TTM CFF for Allarity Therapeutics?
Allarity Therapeutics all-time high TTM cash flow from financing activities is $34.66 M
What is Allarity Therapeutics TTM CFF year-on-year change?
Over the past year, ALLR TTM cash flow from financing activities has changed by +$21.86 M (+194.90%)